IRVINE, CA / ACCESSWIRE / January 31, 2017 / Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Zagg Inc. (“Zagg” or the “Company”) (NASDAQ: ZAGG) concerning possible violations of federal securities laws.

If you purchased shares of Zagg. and want more information, free of charge, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

The purpose of the investigation is to determine if Zagg’s subsidiary company, mophie inc. (“mophie”), exaggerated inventory and sales return reserves in violation of Generally Accepted Accounting Principles; and, if Zagg exxagerated mophie’s working capital during the Class Period.

When releasing third quarter 2016 financial results, Zagg reported a non-cash net mophie impairment charge of $24.3 million “related to disputes in acquisition-date value of working capital.” When this information was released to the investing public, shares of Zagg fell 13.2%, causing investors serious harm.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453965

LOS ANGELES, CA / ACCESSWIRE / January 31, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against PixarBio Corporation (“PixarBio” or the “Company”) (OTC PINK: PXRB) concerning possible violations of federal securities laws between October 31, 2016 and January 20, 2017 inclusive (the “Class Period”). Investors, who purchased or otherwise acquired shares during the Class Period, should contact the firm prior to the March 27, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

On January 23, 2017, the SEC revealed the temporary suspension of trading in the stocks of PixarBio “because the market for the security appears to reflect manipulative or deceptive activities and because of questions regarding the accuracy of assertions by PixarBio in press releases and its Form S-1 concerning, among other things: (1) the company’s business combinations and current shareholders; (2) the identity and qualifications of key shareholders and employees; and (3) the company’s current and prospective development efforts.” When this news was released to the public, the value of PixarBio dropped, causing investors serious harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 453957

LOS ANGELES, CA / ACCESSWIRE / January 31, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Banc of California, Inc. (“Banc of California” or the “Company”) (NYSE: BANC) concerning possible violations of federal securities laws between August 7, 2015 and January 23, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the March 24, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

Seeking Alpha released an article claiming that Banc of California had concealed several connections between it and Jason Galanis, who has been convicted of criminal securities fraud. Specifically, the Complaint maintains that: Banc of California CEO Jason Sugarman was the founder, CEO, and indirect owner of a company controlled by Galanis; and that separately, Galanis controlled Banc of California’s founding shareholder.The Complaint further claims that Banc of California was using an off-balance sheet entity to render loans to insiders.

Then, on November 10, 2016, Banc of California revealed it would be stalling the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2016 so that its Special Committee could complete a review into the aforementioned improper relationships and related party transactions. On January 23, 2017, Banc of California stated that the Securities and Exchange Commission is pursuing a formal order of investigation directed at these same issues.

When this news was released to the public, the value of Banc dropped, causing investors serious harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 453964

IRVINE, CA / ACCESSWIRE / January 31, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Rio Tinto plc (“Rio Tinto” or the “Company”) (NYSE: RIO). Investors, who purchased or otherwise acquired shares between March 16, 2012 and November 14, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the February 10, 2017 lead plaintiff motion deadline.

If you purchased shares of Rio Tino during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The Complaint claims that during the Class Period, Rio Tinto issued materially false and misleading statements to investors and/or failed to disclose that: the Company violated anti-corruption laws in the Simandou project; that these violations would subject Rio Tinto to fines and negative comments; and that due to the forgoing, Rio Tinto’s public statements were materially false and misleading at all relevant times. When this information was revealed to the public, the value of Rio Tinto fell, causing investors harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453963

NEW YORK, NY / ACCESSWIRE / January 31, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Centrue Financial Corporation (NASDAQ: CFCB) stock prior to January 26, 2017.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Centrue to Midland States Bancorp, Inc. (NASDAQ: MSBI). Under the terms of the transaction, Centrue shareholders may elect to receive 0.7604 shares of Midland common stock, a fixed consideration of $26.75 in cash, or a combination of cash and stock for each share of Centrue common stock they own. To learn more about the action and your rights, go to: http://zlk.9nl.com/centrue-cfcb, or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 453961

IRVINE, CA / ACCESSWIRE / January 31, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against The Western Union Company (“Western Union” or the “Company”) (NYSE: WU). Investors, who purchased or otherwise acquired Western Union securities on the open market between February 24, 2012 and January 19, 2017, both dates inclusive (the “Class Period”), are advised to contact the firm prior to the March 27, 2017 lead plaintiff deadline.

If you purchased shares of Western Union during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On January 19, 2017, the U.S. Department of Justice and the Federal Trade Commission revealed that Western Union confessed to “aiding and abetting wire fraud” by permitting illicit money transfers to benefit human traffickers, money laundering schemes, and otherwise enable the transfer of “dirty money.”

Western Union also admitted agents were covering money laundering transactions to avoid detection. The Company has agreed on a $586 million settlement. When this information was announced to the public, the value of Western Union fell, causing investors serious harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453959

NEW YORK, NY / ACCESSWIRE / January 31, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased Novo American Depositary Receipts (“ADR”) between April 30, 2015 and October 27, 2016, both dates inclusive (the “Class Period”). Investors with losses in excess of $1 million are advised to join this case by visiting the firm’s site: http://www.bgandg.com/nvo.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Novo reported materially false and misleading Company earnings and predications, in that they were inflated through the collusive price fixing of Novo’s insulin drugs. The Complaint also alleges that Novo misrepresented and concealed the true extent of the pricing pressures it was experiencing from pharmacy benefit managers.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/nvo, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. Investors with losses in excess of $1 million in Novo, you have until March 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 452757